An I.T.M.O. Group Study on Second-line Treatment in Advanced Epithelial Ovarian Cancer: an Attempt to Identify Clinical and Biological Factors Determining Prognosis

Author： Di Leo A.   Bajetta E.   Biganzoli L.   Bohm S.   Mariani L.   Menard S.   Pilotti S.   Fabbiani M.   Gebbia V.   Oriana S.   Ottone F.   Riboldi G.   Sava C.   Spatti G.   Zunino F.   Di Re F.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.31, Iss.13, 1995-12, pp. : 2248-2254

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Phase 2 Study with Epirubicin as Second-Line Treatment of Patients with Advanced Epithelial Ovarian Cancer

By Havsteen H.   Bertelsen K.   Gadeberg C.C.   Jacobsen A.   Kamby C.   Sandberg E.   Sengelov L.  

Gynecologic Oncology, Vol. 63, Iss. 2, 1996-11 ,pp. : 210-215

Academic Press

Access to resources Recommend Favorite

Taxol as Second-Line Treatment in Patients with Advanced Ovarian Cancer after Platinum-Based First-Line Chemotherapy

By Mayerhofer K.   Kucera E.   Zeisler H.   Speiser P.   Reinthaller A.   Sevelda P.  

Gynecologic Oncology, Vol. 64, Iss. 1, 1997-01 ,pp. : 109-113

Elsevier

Access to resources Recommend Favorite

Phase I trial of weekly irinotecan combined with UFT as second-line treatment for advanced colorectal cancer

By Alonso V.   Escudero P.   Zorrilla M.   Isla M.D.   Herrero A.   Mayordomo J.I.   Martinez-Trufero J.   Saenz A.   Tres A.   Anton A.  

European Journal of Cancer, Vol. 37, Iss. 18, 2001-12 ,pp. : 2385-2391

Elsevier

Access to resources Recommend Favorite

Oral Treosulfan as Second-Line Treatment in Platinum-Resistant Ovarian Cancer: A Phase II Study

By Keldsen N.   Madsen E.L.   Havsteen H.   Kamby C.   Laursen L.   Sandberg E.   on behalf of The Danish Ovarian Cancer Study Group  

Gynecologic Oncology, Vol. 69, Iss. 2, 1998-05 ,pp. : 100-102

Elsevier

Access to resources Recommend Favorite

Vinorelbine as first-line or second-line therapy for advanced breast cancer: A Phase I-II trial by the Danish Breast Cancer Co-operative Group

By Langkjer Sven   Ejlertsen Bent   Mouridsen Henning   Andersen Jørn   Møller Nielsen Mette   Åge Møller Knud   Lindegaard Madsen Ebbe   Haarh Vera  

Acta Oncologica, Vol. 47, Iss. 4, 2008-01 ,pp. : 735-739

Informa Healthcare

Access to resources Recommend Favorite